Abstract
The clinical efficacy of lithium in the prophylaxis of recurrent affective episodes in bipolar disorder is characterized by a lag in onset and remains for weeks to months after discontinuation. Thus, the long-term therapeutic effect of lithium likely requires reprogramming of gene expression. Protein kinase C and glycogen synthase kinase-3 signal transduction pathways are perturbed by chronic lithium at therapeutically relevant concentrations and have been implicated in modulating synaptic function in nerve terminals. These signaling pathways offer an opportunity to model critical signals for altering gene expression programs that underlie adaptive responses of neurons to long-term lithium exposure. While the precise physiological events critical for the clinical efficacy of lithium remain unknown, we propose that linking lithium-responsive genes as a regulatory network will provide a strategy to identify signature gene expression patterns that distinguish between therapeutic and nontherapeutic actions of lithium.
References
Goodwin FK, Ghaemi SN . The impact of the discovery of lithium on psychiatric thought and practice in the USA and Europe. Aust NZ J Psychiatry 1999; 33 (Suppl): S54–S64.
Lenox RH, Manji HK . Lithium. In: Nemeroff C, Schatzberg A (eds). APA Textbook of Psychopharmacology. Washington, DC: APA Press, Inc: 1998, pp. 303–314.
Lenox RH, Hahn CG . Overview of the mechanism of action of lithium in the brain: fifty-year update. J Clin Psychiatry 2000; 61: 5–15.
Hudson CJ, Young LT, Li PP, Warsh JJ . CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 1993; 13: 278–293.
Lenox RH . Role of receptor coupling to phosphoinositide metabolism in the therapeutic action of lithium. In: Ehrlich Y (ed). Molecular Mechanisms of Neuronal Responsiveness. New York: Plenum. Adv Exp Med 1987; 221: 515–530.
Post RM . Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149: 999–1010.
Suppes T, Baldessarini RJ, Faedda GL, Tohen M . Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991; 48: 1082–1088.
Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M . Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 1993; 50: 448–455.
Tondo L, Baldessarini RJ, Hennen J, Floris G . Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry 1998; 155: 638–645.
Lenox RH, McNamara RK, Papke RL, Manji HK . Neurobiology of lithium: an update. J Clin Psychiatry 1998; 59: 37–47.
Manji HK, Lenox RH . Lithium: a molecular transducer of mood-stabilization in the treatment of bipolar disorder. Neuropsychopharmacology 1998; 19: 161–166.
Jope RS . Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry 1999; 4: 117–128.
Williams RS, Harwood AJ . Lithium therapy and signal transduction. Trends Pharmacol Sci 2000; 21: 61–64.
Manji HK, Lenox RH . Signaling: cellular insights into the pathophysiology of bipolar disorder [In Process Citation]. Biol Psychiatry 2000; 48: 518–530.
Hyman SE, Nestler EJ . Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 1996; 153: 151–162.
York JD, Ponder JW, Majerus PW . Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure. Proc Natl Acad Sci USA 1995; 92: 5149–5153.
Phiel C, Klein P . Molecular targets of lithium action. Annu Rev Pharmacol Toxicol 2001; 41: 789–813.
Hallcher LM, Sherman WR . The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 1980; 255: 10896–10901.
Sherman WR, Gish BG, Honchar MP, Munsell LY . Effects of lithium on phosphoinositide metabolism in vivo. Fed Proc 1986; 45: 2639–2646.
Irvine RF . Nuclear lipid signaling. Sci STKE 2002; 2002: RE13.
Majerus PW . Inositol phosphate biochemistry. Annu Rev Biochem 1992; 61: 225–250.
Acharya JK, Labarca P, Delgado R, Jalink K, Zuker CS . Synaptic defects and compensatory regulation of inositol metabolism in inositol polyphosphate 1-phosphatase mutants. Neuron 1998; 20: 1219–1229.
Manji HK, Lenox RH . Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 1999; 46: 1328–1351.
Nahorski SR, Ragan CI, Challiss RA . Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol Sci 1991; 12: 297–303.
Berridge MJ, Downes CP, Hanley MR . Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 1982; 206: 587–595.
Kendall DA, Nahorski SR . Acute and chronic lithium treatments influence agoinst and depolarization-stimulated inositol phospholipid hydrolysis in rat cerebral cortex. J Pharmacol Exp Ther 1987; 241: 1023–1027.
Kennedy ED, Challiss RA, Nahorski SR . Lithium reduces the accumulation of inositol polyphosphate second messengers following cholinergic stimulation of cerebral cortex slices. J Neurochem 1989; 53: 1652–1655.
Kennedy ED, Challiss RA, Ragan CI, Nahorski SR . Reduced inositol polyphosphate accumulation and inositol supply induced by lithium in stimulated cerebral cortex slices. Biochem J 1990; 267: 781–786.
Kofman O, Belmaker RH, Grisaru, N, Alpert C, Fuchs I, Katz V, Rigler O . Myo-inositol attenuates two specific behavioral effects of acute lithium in rats. Psychopharmacol Bull 1991; 27: 185–190.
Tricklebank MD, Singh L, Jackson A, Oles RJ . Evidence that a proconvulsant action of lithium is mediated by inhibition of myo-inositol phosphatase in mouse brain. Brain Res 1991; 558: 145–148.
Watson DG, Lenox RH . Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation. J Neurochem 1996; 67: 767–777.
Fisher SK, Novak JE, Agranoff BW . Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 2002; 82: 736–754.
Gani D, Downes CP, Batty I, Bramham J . Lithium and myo-inositol homeostasis. Biochim Biophys Acta 1993; 1177: 253–269.
Moore GJ, Bedchuk JM, Parrish JK, Faulk MW, Arjken CL, Strahl-Bevacqua J, Marji HK . Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 1999; 156: 1902–1908.
Manji HK, Lenox RH . Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C. Synapse 1994; 16: 11–28.
Manji HK, Etcheberrigaray R, Chen G, Olds JL . Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the alpha isozyme. J Neurochem 1993; 61: 2303–2310.
Manji HK, Bersudsky Y, Chen G, Belmaker RH, Potter WZ . Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol. Neuropsychopharmacology 1996; 15: 370–381.
Jope RS, Song L . AP-1 and NF-kappaB stimulated by carbachol in human neuroblastoma SH-SY5Y cells are differentially sensitive to inhibition by lithium. Brain Res Mol Brain Res 1997; 50: 171–180.
Wang HY, Markowitz P, Levinson D, Undie AS, Freidman E . Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients. J Psychiatr Res 1999; 33: 171–179.
Soares JC, Chen G, Dippold CS et al. Concurrent measures of protein kinase C and phophoinositides in lithium-treated bipolar patients and healthy individuals: a preliminiary study. Psychiatry Res 2000; 95: 109–118.
Wang H, Freidman E . Increased association of brain protein kinase C with the receptor for activated C kinase-1 (RACK1) in bipolar affective disorder. Biol Psychiatry 2001; 50: 364–370.
Bebchuk JM, Arfken CL, Dolan-Manji S, Murphy J, Hasanat K, Manji HK . A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry 2000; 57: 95–97.
Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW . Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 1997; 272: 24735–24738.
Farr III GH, Ferkey DM, Yost C, Pierce SB, Weaver C, Kimelman D . Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J Cell Biol 2000; 148: 691–702.
McKendry R, Hsu SC, Harland RM, Grosschedl R . LEF-1/TCF proteins mediate wnt-inducible transcription from the Xenopus nodal-related 3 promoter. Dev Biol 1997; 192: 420–431.
Brannon M, Gomperts M, Sumoy L, Moon RT, Kimelman D . A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate drosal axis specification in Xenopus. Genes Dev 1997; 11: 2359–2370.
Riese J, Yu X, Munnerlyn A et al. LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic. Cell 1997; 88: 777–787.
Shtutman M, Zhurinsky J, Simcha I et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999; 96: 5522–5527.
Tetsu O, McCormick F . Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422–426.
He TC, Sparks AB, Rago C et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509–1512.
van der Heyden MA, Rook MB, Hermans MM et al. Identification of connexin43 as a functional target for Wnt signalling. J Cell Sci 1998; 111: 1741–1749.
Bradley RS, Cowin P, Brown AM . Expression of Wnt-1 in PC12 cells results in modulation of plakoglobin and E-cadherin and increased cellular adhesion. J Cell Biol 1993; 123: 1857–1865.
Mai L, Jope RS, Li X . BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. J Neurochem 2002; 82: 75–83.
Galceran J, Miyashita-Lin EM, Devaney E, Rubenstein JL, Grosschedl R . Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. Development 2000; 127: 469–482.
Graef IA, Mermelstein PG, Stankunas K et al. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature 1999; 401: 703–708.
Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS . Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 1997; 185: 82–91.
Klein PS, Melton DA . A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996; 93: 8455–8459.
Yuan P-X, Huang L-D, Jiang Y-M, Gutkind JS, Manji HK, Chen G . The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J Biol Chem 2001; 276: 31674–31683.
Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS . Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001; 276: 36734–36741.
Hall AC, Brennan A, Goold RG et al. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Mol Cell Neurosci 2002; 20: 257–270.
Lovestone S, Davis DR, Webster MT et al. Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations. Biol Psychiatry 1999; 45: 995–1003.
Hong M, Chen DC, Klein PS, Lee VM . Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 1997; 272: 25326–25332.
Munoz-Montano JR, Moreno FJ, Avila J, Diaz-Nido J . Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett 1997; 411: 183–188.
Eldar-Finkelman H . Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med 2002; 8: 126–132.
Goode N, Hughes K, Woodgett JR, Parker PJ . Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J Biol Chem 1992; 267: 16878–16882.
Chen RH, Ding WV, McCormick F . Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase. C. J Biol Chem 2000; 275: 17894–17899.
Cook D, Fry M, Hughes K, Sumathipala R, Woodgett J, Dale T . Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C. EMBO J 1996; 15: 4526–4536.
Sheldahl LC, Park M, Malbon CC, Moon RT . Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr Biol 1999; 9: 695–698.
Malbon CC, Wang H, Moon RT . Wnt signaling and heterotrimeric G-proteins: strange bedfellows or a classic romance? Biochem Biophys Res Commun 2001; 287: 589–593.
Liu T, DeCostanzo AJ, Liu X et al. G protein signaling from activated rat frizzled-1 to the beta-catenin-Lef-Tcf pathway. Science 2001; 292: 1718–1722.
Chen G, Hasanat KA, Bebchuk JM, Moore GJ, Glitz D, Manji HK . Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. Psychosom Med 1999; 61: 599–617.
Chen RW, Chuang DM . Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 1999; 274: 6039–6042.
Chalecka-Franaszek E, Chuang DM . Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neutrons. Proc Natl Acad Sci USA 1999; 96: 8745–8750.
Berglund K, Midorikawa M, Tachibana M . Increase in the pool size of releasable synaptic vesicles by the activation of protein kinase C in goldfish retinal bipolar cells. J Neurosci 2002; 22: 4776–4785.
Hori T, Takai Y, Takahashi T . Presynaptic mechanism for phorbol ester-induced synaptic potentiation. J Neurosci 1999; 19: 7262–7267.
Voets T, Toonen RF, Brain EC et al. Munc18-1 promotes large dense-core vesicle docking. Neuron 2001; 31: 581–591.
Cordeiro ML, Umbach JA, Gundersen CB . Lithium ions enhance cysteine string protein gene expression in vivo and in vitro. J Neurochem 2000; 74: 2365–2372.
Buchner E, Gundersen CB . The DnaJ-like cysteine string protein and exocytotic neurotransmitter release. Trends Neurosci 1997; 20: 223–227.
Heckmann M, Adelsberger H, Dudel J . Evoked transmitter release at neuromuscular junctions in wild type and cysteine string protein null mutant larvae of Drosophila. Neurosci Lett 1997; 228: 167–170.
Aderem A . The MARCKS brothers: a family of protein kinase C substrates. Cell 1992; 71: 713–716.
Blackshear PJ . The MARCKS family of cellular protein kinase C substrates. J Biol Chem 1993; 268: 1501–1504.
Laux T, Fukami K, Thelen M, Golub T, Frey D, Caroni P . GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J Cell Biol 2000; 149: 1455–1472.
Glaser M, Wanaski S, Buser CA et al. Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains. J Biol Chem 1996; 271: 26187–26193.
Morash SC, Rose SD, Byers DM, Ridgway ND, Cook HW . Overexpression of myristoylated alanine-rich C-kinase substrate enhances activation of phospholipase D by protein kinase C in SK-N-MC human neuroblastoma cells. Biochem J 1998; 332: 321–327.
Goodall AR, Turner NA, Walker JH, Ball SG, Vaughan PF . Activation of protein kinase C-alpha and translocation of the myristoylated alanine-rich C-kinase substrate correlate with phorbol ester-enhanced noradrenaline release from SH-SY5Y human neuroblastoma cells. J Neurochem 1997; 68: 392–401.
Li Y, Martin LD, Spizz G, Adler KB . MARCKS protein is a key molecule regulating MUCIN secretion by human airway epithelial cells in vitro. J Biol Chem 2001; 276: 40982–40990.
Allen LH, Aderem A . A role for MARCKS, the alpha isozyme of protein kinase C and myosin I in zymosan phagocytosis by macrophages. J Exp Med 1995; 182: 829–840.
McNamara RK, Lenox RH . Distribution of the protein kinase C substrates MARCKS and MRP in the postnatal developing rat brain. J Comp Neurol 1998; 397: 337–356.
Stumpo DJ, Bock CB, Tuttle JS, Blackshear PJ . MARCKS deficiency in mice leads to abnormal brain development and perinatal death. Proc Natl Acad Sci USA 1995; 92: 944–948.
Swierczynski SL, Siddhanti SR, Tuttle JS, Blackshear PJ . Nonmyristoylated MARCKS complements some but not all of the developmental defects associated with MARCKS deficiency in mice. Dev Biol 1996; 179: 135–147.
Wang JK, Walaas SI, Sihra TS, Aderem A, Greengard P . Phosphorylation and associated translocation of the 87-kDa protein, a major protein kinase C substrate, in isolated nerve terminals. Proc Natl Acad Sci USA 1989; 86: 2253–2256.
Lu D, Yang H, Lenox RH, Raizada MK . Regulation of angiotensin II-induced neuromodulation by MARCKS in brain neurons. J Cell Biol 1998; 142: 217–227.
Ouimet CC, Wang JK, Walaas SI, Albert KA, Greengard P . Localization of the MARCKS (87 kDa) protein, a major specific substrate for protein kinase C, in rat brain. J Neurosci 1990; 10: 1683–1698.
Yang H, Wang X, Sumners C, Raizada MK . Obligatory role of protein kinase Cbeta and MARCKS in vesicular trafficking in living neurons. Hypertension 2002; 39: 567–572.
McNamara RK, Stumpo DJ, Morel LM et al. Effect of reduced myristoylated alanine-rich C kinase substrate expression on hippocampal mossy fiber development and spatial learning in mutant mice: transgenic rescue and interactions with gene background. Proc Natl Acad Sci USA 1998; 95: 14517–14522.
Ramakers GM, McNamara RK, Lenox RH, De Graan PN . Differential changes in the phosphorylation of the protein kinase C substrates myristoylated alanine-rich C kinase substrate and growth-associated protein-43/B-50 following Schaffer collateral long-term potentiation and long-term depression. J Neurochem 1999; 73: 2175–2183.
Hussain R, McNamara RK, Stumpo DJ et al. Effect of MARCKS overexpression on hippocampal long-term potentiation and hippocampal-dependent learning in transgenic mice. Soc Neurosci Abstracts 2000; 26: 1511.
Lenox RH, Watson DG, Patel J, Ellis J . Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res 1992; 570: 333–340.
Wang L, Liu X, Lenox RH . Transcriptional down-regulation of MARCKS gene expression in immortalized hippocampal cells by lithium. J Neurochem 2001; 79: 816–825.
Watson DG, Wainer BH, Lenox RH . Phorbol ester- and retinoic acid-induced regulation of the protein kinase C substrate MARCKS in immortalized hippocampal cells. J Neurochem 1994; 63: 1666–1674.
Watson DG, Watterson JM, Lenox RH . Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood statilizers. J Pharmacol Exp Ther 1998; 285: 307–316.
Lenox RH, McNamara RK, Watterson JM, Watson DG . Myristoylated alanine-rich C kinase substrate (MARKCS): a molecular target for the therapeutic action of mood stabilizers in the brain? J Clin Psychiatry 1996; 57: 23–31; discussion 32–33.
Williams RS, Cheng L, Mudge AW, Harwood AJ . A common mechanism of action for three mood-stabilizing drugs. Nature 2002; 417: 292–295.
Wang L, Liu X, Lenox RH . Transcriptional regulation of mouse MARCKS promoter in immortalized hippocampal cells. Biochem Biophys Res Commun 2002; 292: 969–979.
Herbert A, Rich A . The biology of left-handed Z-DNA. J Biol Chem 1996; 271: 11595–11598.
Bosetti F, Seemann R, Bell JM et al. Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration. Brain Res Bull 2002; 57: 205–209.
de la Fuente A, Brazhnik P, Mendes P . Linking the genes: inferring quantitative gene networks from microarray data. Trends Genet 2002; 18: 395–398.
Bowden AC . Metabolic control analysis in biotechnology and medicine. Nat Biotechnol 1999; 17: 641–643.
Iyer VR, Horak CE, Scafe CS, Botstein D, Snyder M, Brown PO . Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF. Nature 2001; 409: 533–538.
Ren B, Robert F, Wyrick JJ et al. Genome-wide location and function of DNA binding proteins. Science 2000; 290: 2306–2309.
Weinmann AS, Yan PS, Oberley MJ, Huang TH, Famham PJ . Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev 2002; 16: 235–244.
Horak CE, Mahajan MC, Luscombe NM, Gerstein M, Weissman SM, Snyder M . GATA-1 binding sites mapped in the beta-globin locus by using mammalian chlp–chip analysis. Proc Natl Acad Sci USA 2002; 99: 2924–2929.
Weinmann AS, Farnham PJ . Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 2002; 26: 37–47.
Davidson EH, Rast JP, Oliveri P et al. A provisional regulatory gene network for specification of endomesoderm in the sea urchin embryo. Dev Biol 2002; 246: 162–190.
Oliveri P, Carrick DM, Davidson EH . A regulatory gene network that directs micromere specification in the sea urchin embryo. Dev Biol 2002; 246: 209–228.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lenox, R., Wang, L. Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks. Mol Psychiatry 8, 135–144 (2003). https://doi.org/10.1038/sj.mp.4001306
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001306
- Springer Nature Limited
Keywords
This article is cited by
-
Primary cilia suppress the fibrotic activity of atrial fibroblasts from patients with atrial fibrillation in vitro
Scientific Reports (2024)
-
Transcriptomics and miRNomics data integration in lymphoblastoid cells highlights the key role of immune-related functions in lithium treatment response in Bipolar disorder
BMC Psychiatry (2022)
-
LiCl treatment leads to long-term restoration of spine maturation and synaptogenesis in adult Tbr1 mutants
Journal of Neurodevelopmental Disorders (2022)
-
Lithium chloride sensitivity connects the activity of PEX11 and RIM20 to the translation of PGM2 and other mRNAs with structured 5’-UTRs
Molecular and Cellular Biochemistry (2022)
-
Integrative analysis of lithium treatment associated effects on brain structure and peripheral gene expression reveals novel molecular insights into mechanism of action
Translational Psychiatry (2020)